← Back to Search

DISE Phenotyping for Obstructive Sleep Apnea (DISE-PhOP Trial)

N/A
Recruiting
Led By Raj C Dedhia, MD, MSCR
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (≥ 18yrs) willing and capable of providing informed consent
English-speaking & able to give Informed Consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 3 months of enrollment
Awards & highlights

Summary

This trial will use DISE to examine the upper airway and determine if there are any obstructions in the airway that could cause problems during sleep. It will also use nasal pressure and CT/ultrasound imaging to help predict success of standard surgical interventions to correct any problems found.

Who is the study for?
This trial is for adults over 18 who speak English and can consent to participate. It's specifically for those referred or scheduled for a DISE procedure, which examines the upper airway during sleep-like conditions, and are looking for alternatives to CPAP treatment for breathing issues during sleep.
What is being tested?
The study tests how well nasal pressure (CPAP) applied during DISE can identify functional causes of airflow blockage in sleep. It combines this with anatomic measurements from CT scans and submental ultrasound to predict success of standard surgical treatments.
What are the potential side effects?
Since this trial involves diagnostic procedures like DISE, CT scans, and ultrasounds rather than medications, side effects may include discomfort from the equipment used or anxiety related to undergoing the procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years or older and can give my consent.
Select...
I speak English and can give informed consent.
Select...
I am referred for or scheduled to have a DISE procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 3 months of enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3 months of enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Identify the pathogenic determinants of airway obstruction at specific sites of pharyngeal collapse by characterizing upper airway pressure-flow/area relationships during DISE to predict responses to upper airway surgery
Secondary study objectives
Compare positive airway pressure levels obtained from natural sleep to those during DISE
Complement videoendoscopic DISE findings with synchronous ultrasound imaging
Correlation of anatomic measurements from computerized tomography (CT) scans to physiologic findings from DISE
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Drug-Induced Sleep EndoscopyExperimental Treatment2 Interventions
Drug-Induced Sleep Endoscopy

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,053 Previous Clinical Trials
43,012,886 Total Patients Enrolled
Raj C Dedhia, MD, MSCRPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
63 Total Patients Enrolled

Media Library

Drug-induced sleep endoscopy (DISE) Clinical Trial Eligibility Overview. Trial Name: NCT05050383 — N/A
Obstructive Sleep Apnea Research Study Groups: Drug-Induced Sleep Endoscopy
Obstructive Sleep Apnea Clinical Trial 2023: Drug-induced sleep endoscopy (DISE) Highlights & Side Effects. Trial Name: NCT05050383 — N/A
Drug-induced sleep endoscopy (DISE) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05050383 — N/A
~97 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top